| LAMTX | VSTSX | LAMTX / VSTSX | |
| Total Expense Ratio | 0.64 | 0.01 | 6,400% |
| Annual Report Gross Expense Ratio | 0.64 | 0.01 | 6,400% |
| Fund Existence | 11 years | 10 years | - |
| Gain YTD | 2.489 | 1.382 | 180% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.82B | 2.06T | 0% |
| Annual Yield % from dividends | 0.85 | 1.12 | 76% |
| Returns for 1 year | 12.04 | 14.81 | 81% |
| Returns for 3 years | 50.65 | 64.11 | 79% |
| Returns for 5 years | 48.76 | 68.33 | 71% |
| Returns for 10 years | 122.95 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| UAPIX | 84.88 | 0.48 | +0.57% |
| ProFunds UltraSmall Cap Inv | |||
| PPSFX | 19.48 | 0.04 | +0.21% |
| Principal Large Cap Value III R3 | |||
| JFDRX | 13.75 | -0.05 | -0.36% |
| JHancock Financial Industries R6 | |||
| PRSCX | 60.80 | -0.45 | -0.73% |
| T. Rowe Price Science & Tech | |||
| ECHSX | 13.23 | -0.17 | -1.27% |
| Eaton Vance Worldwide Health Sci C | |||